Analysis of vaccination strategy against cystic echinococcosis developed in the Province of Río Negro, Argentina: 12 years of work.


Journal

Veterinary parasitology
ISSN: 1873-2550
Titre abrégé: Vet Parasitol
Pays: Netherlands
ID NLM: 7602745

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 11 04 2022
revised: 23 08 2022
accepted: 24 08 2022
pubmed: 3 9 2022
medline: 14 9 2022
entrez: 2 9 2022
Statut: ppublish

Résumé

Cystic echinococcosis (CE) is a zoonosis caused by species of the complex Echinococcus granulosus, sensu lato in their larval stage. It is an endemic disease in the province of Río Negro, where small farmers generally have both sheep and goats. Lamb vaccination with EG95 was incorporated in 2009 with very good results: in fact, it contributed to a significant drop in prevalence of infection in both sheep and goats, when determined by necropsy and serology in 2018. In the design of the activity, it was decided not to vaccinate goats in order to minimize the operational requirements of vaccination and comments from producers about the rarity of observing hydatid cysts in goat viscera were considered. To identify causes which can still generate infection in dogs, and to detect species/genotypes in circulation in the province of Río Negro. In indigenous reserves comprised within the area of lamb vaccination with 3 doses of EG95, (dose 1 in December, dose 2 in January and dose 3 in December of the year following, at the time of application of dose 1 to the new lambs). Prevalence in adult goats and sheep was determined by necropsy and serology (ELISA). Infective species/genotypes present in the work area and in the rest of the province of Río Negro were identified by Cox1 mitochondrial gene sequencing. Epidemiological analysis was completed with surveys among farmers about slaughter habits for human consumption. Through serology and necropsy, infection rates in vaccinated and nonvaccinated sheep were significantly different (21% versus 66%). Non-vaccinated sheep and non-vaccinated goats were also significantly different in that there was less infection in goats compared to sheep (7% versus 66% for necropsy, 30% versus 61% for serology); After many years of sheep vaccination the infection positives were low, and differences between vaccinated sheep and non-vaccinated goats turned out non-significant (21% versus 7%). With reference to epidemiology and control along the period 2018-2022, PZQ dosing of dogs 4 times a year was maintained, and 2 extra deworming tasks were introduced together with dose 1 and 2 of EG95, performed by the veterinary vaccination team, ensuring the ingestion of PZQ by dogs. Assessment of animal slaughter for consumption in 41 producers showed that 21 of them slaughter a monthly average of 18 goats (an average of 0.43 goat per month per farm) and 36 in all slaughter 35 old sheep in a year (average of 0.85 sheep per month per farm). With respect to identification of species/genotypes as from 2010, genotypes G1 have been found in 11 sheep (out of which 6 belong to vaccination zone) and genotypes G7, in one pig. A goat cyst within vaccination zone turned out unfertile and it was not possible to sequence it. Design and implementation of a vaccine programme combined with the use of PZQ resulted as cost-effective, since it was possible to maintain the vaccine over time, with clear impact on prevalence decrease in sheep and goats.

Identifiants

pubmed: 36054969
pii: S0304-4017(22)00144-3
doi: 10.1016/j.vetpar.2022.109790
pii:
doi:

Substances chimiques

Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109790

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

José Luis Labanchi (JL)

Coordinación de Salud Ambiental, Ministerio de Salud de la Provincia de Rio Negro, Viedma, Argentina; Escuela de Veterinaria, Universidad Nacional de Rio Negro, Choele Choel, Argentina.

Thelma V Poggio (TV)

Instituto de Ciencia y Tecnología Cesar Milstein-CONICET, Buenos Aires, Argentina.

Ariana Gutiérrez (A)

Instituto Nacional de Microbiología "ANLIS-MALBRAN", Buenos Aires, Argentina.

Guillermo Mujica (G)

Coordinación de Salud Ambiental, Ministerio de Salud de la Provincia de Rio Negro, Viedma, Argentina.

Daniel Araya (D)

Coordinación de Salud Ambiental, Ministerio de Salud de la Provincia de Rio Negro, Viedma, Argentina.

Claudia Grizmado (C)

Coordinación de Salud Ambiental, Ministerio de Salud de la Provincia de Rio Negro, Viedma, Argentina.

Arnoldo Calabro (A)

Coordinación de Salud Ambiental, Ministerio de Salud de la Provincia de Rio Negro, Viedma, Argentina.

Pablo Crowley (P)

Escuela de Veterinaria, Universidad Nacional de Rio Negro, Choele Choel, Argentina.

Marcos Arezo (M)

Coordinación de Salud Ambiental, Ministerio de Salud de la Provincia de Rio Negro, Viedma, Argentina.

Marcos Seleiman (M)

Coordinación de Salud Ambiental, Ministerio de Salud de la Provincia de Rio Negro, Viedma, Argentina.

Eduardo Herrero (E)

Coordinación de Salud Ambiental, Ministerio de Salud de la Provincia de Rio Negro, Viedma, Argentina.

Luis Sepulveda (L)

Coordinación de Salud Ambiental, Ministerio de Salud de la Provincia de Rio Negro, Viedma, Argentina.

Gabriel Talmon (G)

Coordinación de Salud Ambiental, Ministerio de Salud de la Provincia de Rio Negro, Viedma, Argentina.

Oscar Diaz (O)

Coordinación de Salud Ambiental, Ministerio de Salud de la Provincia de Rio Negro, Viedma, Argentina.

Edmundo Larrieu (E)

Escuela de Veterinaria, Universidad Nacional de Rio Negro, Choele Choel, Argentina; Facultad de Ciencias Veterinarias, Universidad Nacional de La Pampa, General Pico, Argentina. Electronic address: elarrieu@unrn.edu.ar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH